IFNG and tuberculosis: Previous works highlighted a general decrease in IFN-γ levels across TB treatment (13–18), and a study on QuantiFERON Gold In-Tube highlighted the presence of downregulated non-TB specific IFN-γ responses (Mitogen tube) were associated with poor treatment outcomes (19).